SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-014996
Filing Date
2023-08-15
Accepted
2023-08-15 16:10:29
Documents
12
Period of Report
2023-08-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K aytu-20230811x8k.htm   iXBRL 8-K 38684
  Complete submission text file 0001558370-23-014996.txt   157984

Data Files

Seq Description Document Type Size
2 EX-101.SCH aytu-20230811.xsd EX-101.SCH 3129
3 EX-101.LAB aytu-20230811_lab.xml EX-101.LAB 15901
4 EX-101.PRE aytu-20230811_pre.xml EX-101.PRE 10058
6 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20230811x8k_htm.xml XML 4866
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 231174943
SIC: 2834 Pharmaceutical Preparations